Trial · NCT02536040
Stopping Cavities Study: Diammine Silver Fluoride
NCT02536040, Phase 3, Completed, Advantage Dental Services, LLC; results first posted 2020-01-23
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Stopping Cavities Study: Diammine Silver Fluoride. Trials, record NCT02536040. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02536040
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Stopping Cavities Study: Diammine Silver Fluoride
- NCT number
- NCT02536040
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 66 participants, actual
- Lead sponsor
- Advantage Dental Services, LLC
- Conditions
- Dental Caries
- Interventions
- 38% diammine silver fluoride, Water
- First posted
- 2015-08-31
- Last updated
- 2020-01-23
- Results first posted
- 2020-01-23
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dental Caries Activity | 14-21 days | Proportion of treated teeth with active decay that were arrested by the treatment measured using the Nyvad criterion code 6 reflecting hardness of the lesion and color change |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Dental Caries Activity | 14-21 days | Proportion of arrested caries lesions | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Dental Caries Activity | 38% Diamine Silver Fluoride | .72 | Standard Deviation .38 | Proportion of arrested caries lesions | |
| Dental Caries Activity | Water | .05 | Standard Deviation .18 | Proportion of arrested caries lesions |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 38% Diamine Silver Fluoride | 30 | |
| Overall Study | STARTED | Water | 36 | |
| Overall Study | COMPLETED | 38% Diamine Silver Fluoride | 29 | |
| Overall Study | COMPLETED | Water | 35 | |
| Overall Study | NOT COMPLETED | 38% Diamine Silver Fluoride | 1 | |
| Overall Study | NOT COMPLETED | Water | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 38% Diamine Silver Fluoride | 0 | 29 |
| Total, all-cause mortality | Water | 0 | 35 |
| Total, other adverse events | 38% Diamine Silver Fluoride | 0 | 29 |
| Total, other adverse events | Water | 0 | 35 |
| Total, serious adverse events | 38% Diamine Silver Fluoride | 0 | 29 |
| Total, serious adverse events | Water | 0 | 35 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| 38% Diamine Silver Fluoride vs Water: deaths from any cause | Trial comparisons |
| 38% Diamine Silver Fluoride vs Water: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02536040
GET https://conductscience.org/api/trials/v1/NCT02536040/registered